相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Longitudinal assessment of B-RAF V595E levels in the peripheral cell-free tumor DNA of a 10-year-old spayed female Korean Jindo dog with unresectable metastatic urethral transitional cell carcinoma for monitoring the treatment response to a RAF inhibitor (sorafenib)
Jung-Hyun Kim et al.
VETERINARY QUARTERLY (2021)
Quantitative analysis of the BRAF V595E mutation in plasma cell-free DNA from dogs with urothelial carcinoma
Michihito Tagawa et al.
PLOS ONE (2020)
Cross-species oncogenic signatures of breast cancer in canine mammary tumors
Tae-Min Kim et al.
NATURE COMMUNICATIONS (2020)
Identifying the ErbB/MAPK Signaling Cascade as a Therapeutic Target in Canine Bladder Cancer
Kathryn E. Cronise et al.
MOLECULAR PHARMACOLOGY (2019)
Diverse Mechanisms of BRAF Inhibitor Resistance in Melanoma Identified in Clinical and Preclinical Studies
Stephen A. Luebker et al.
FRONTIERS IN ONCOLOGY (2019)
Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture
Mohamed Elbadawy et al.
CANCER SCIENCE (2019)
Targeting Oncogenic BRAF: Past, Present, and Future
Aubhishek Zaman et al.
CANCERS (2019)
Expression of receptor tyrosine kinase targets PDGFR-, VEGFR2 and KIT in canine transitional cell carcinoma
L. Walters et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
Lower Urinary Tract Neoplasia
Maureen A. Griffin et al.
VETERINARY SCIENCES (2018)
Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs
Christopher M. Fulkerson et al.
INTERNATIONAL JOURNAL OF GENOMICS (2017)
Overcoming resistance to BRAF inhibitors
Imanol Arozarena et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma
Alex Kim et al.
EXPERT OPINION ON DRUG DISCOVERY (2016)
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer
Ryan B. Corcoran et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis
Yu Sun et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2015)
Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer-Evidence for a Relevant Model System and Urine-Based Diagnostic Test
Brennan Decker et al.
MOLECULAR CANCER RESEARCH (2015)
RAF inhibitors that evade paradoxical MAPK pathway activation
Chao Zhang et al.
NATURE (2015)
Management of transitional cell carcinoma of the urinary bladder in dogs: A review
Christopher M. Fulkerson et al.
VETERINARY JOURNAL (2015)
BRAF Mutations in Canine Cancers
Hiroyuki Mochizuki et al.
PLOS ONE (2015)
Molecular Homology and Difference between Spontaneous Canine Mammary Cancer and Human Breast Cancer
Deli Liu et al.
CANCER RESEARCH (2014)
Urinary Bladder Cancer in Dogs, a Naturally Occurring Model for Cancer Biology and Drug Development
Deborah W. Knapp et al.
ILAR JOURNAL (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Cancer driver-passenger distinction via sporadic human and dog cancer comparison: a proof-of-principle study with colorectal cancer
J. Tang et al.
ONCOGENE (2014)
Neoadjuvant Treatment of a Solitary Melanoma Brain Metastasis With Vemurafenib
Grant R. Kolar et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma
Kerstin Trunzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Optimization of tumor xenograft dissociation for the profiling of cell surface markers and nutrient transporters
Vincent Petit et al.
LABORATORY INVESTIGATION (2013)
DNMT1: An emerging target in the treatment of invasive urinary bladder cancer
Deepika Dhawan et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Vemurafenib: the first drug approved for BRAF-mutant cancer
Gideon Bollag et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models
Hong Yang et al.
CANCER RESEARCH (2010)
Canine invasive transitional cell carcinoma cell lines: In vitro tools to complement a relevant animal model of invasive urinary bladder cancer
Deepika Dhawan et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Mutational analysis of the BRAF gene in transitional cell carcinoma of the bladder
Ioannis Boulalas et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2009)
Role of Raf kinase in cancer: Therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway
Jared A. Gollob et al.
SEMINARS IN ONCOLOGY (2006)
BRAF mutation in papillary thyroid carcinoma
J Cohen et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601
BH Zhang et al.
EMBO JOURNAL (2000)
Naturally-occurring canine transitional cell carcinoma of the urinary bladder - A relevant model of human invasive bladder cancer
DW Knapp et al.
UROLOGIC ONCOLOGY (2000)
分享论文
